Suvaxyn Circo+MH RTU Europska Unija - hrvatski - EMA (European Medicines Agency)

suvaxyn circo+mh rtu

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - Инактивированные virusnih i инактивированные bakterijska cjepiva - svinje - za aktivne imunizacije svinja s 3 tjedna starosti protiv svinjske цирковирус tipa 2 (pcv2) za smanjenje količine virusa u krvi i лимфоидных tkiva i fekalne prolijevanja, uzrokovane infekcijom s ЦВС2. za aktivnu imunizaciju svinja u dobi od 3 tjedna protiv mycoplasma hyopneumoniae za smanjenje plućnih lezija uzrokovanih infekcijom s m. hyopneumoniae.

Colixin 1 milijun IU prašak za otopinu za injekciju/infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

colixin 1 milijun iu prašak za otopinu za injekciju/infuziju

altamedics d.o.o., vrbani 4, zagreb, hrvatska - kolistimetatnatrij - prašak za otopinu za injekciju/infuziju - 1 milijun iu - urbroj: jedna bočica sadrži 1.000.000 internacionalnih jedinica (iu) kolistimetatnatrija (što odgovara otprilike 80 mg kolistimetatnatrija)

Colixin 2 milijuna IU prašak za otopinu za injekciju/infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

colixin 2 milijuna iu prašak za otopinu za injekciju/infuziju

altamedics d.o.o., vrbani 4, zagreb, hrvatska - kolistimetatnatrij - prašak za otopinu za injekciju/infuziju - 2 milijuna iu - urbroj: jedna bočica sadrži 2.000.000 internacionalnih jedinica (iu) kolistimetatnatrija (što odgovara otprilike 160 mg kolistimetatnatrija)

Porcilis ColiClos Europska Unija - hrvatski - EMA (European Medicines Agency)

porcilis coliclos

intervet international bv - Клостридии filtera tipa c / escherichia coli f4ab / f4ac e. coli / escherichia coli Ф5 / Ф6 e. coli / escherichia coli lt - immunologicals - svinje - za pasivne imunizacije potomstva kroz aktivne imunizacije krmača i подсвинков za smanjenje smrtnosti i kliničkih znakova tijekom prvih dana života, uzrokovano sojevi e. coli koji se izražavaju адгезинов f4ab (k88ab), f4ac (k88ac), Ф5 (u k99) ili f6 (987p) i uzrokovan clostridium filtera tipa c.

Mhyosphere PCV ID Europska Unija - hrvatski - EMA (European Medicines Agency)

mhyosphere pcv id

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svinje - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Jcovden (previously COVID-19 Vaccine Janssen) Europska Unija - hrvatski - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - cjepiva - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Probioflor želučanootporne tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

probioflor želučanootporne tvrde kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - žive liofilizirane bakterije escherichia coli nissle 1917 soje - želučanootporna kapsula, tvrda - 2,5 – 25 x 10^9 cfu živih liofiliziranih bakterija - urbroj: 1 tvrda želučanootporna kapsula sadrži 2,5 – 25 x 10⁹ kolonija (cfu) živih liofiliziranih bakterija escherichia coli soja nissle 1917

Suiseng Coli/C Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

suiseng coli/c

laboratorios hipra, s.a., avinguda la selva 135, 17170 amer (girona), Španjolska - fimbrijski adhezin f4ab e. coli ; fimbrijski adhezin f4ac e. coli ; fimbrijski adhezin f5 e. coli ; fimbrijski adhezin f6 e. coli ; enterotoksoid lt e. coli ; toksoid clostridium perfringens, tip c; toksoid clostridium novyi, tip b - suspenzija za injekciju - svinja (krmača i nazimica)

Spikevax (previously COVID-19 Vaccine Moderna) Europska Unija - hrvatski - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Zulvac 1+8 Ovis Europska Unija - hrvatski - EMA (European Medicines Agency)

zulvac 1+8 ovis

zoetis belgium sa - inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01, inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - bluetongue virus, sheep, inactivated viral vaccines - ovca - aktivna imunizacija ovaca od 1. 5 mjeseci starosti kako bi se spriječila viremija uzrokovana virusom bolesti plavog jezika, serotipovima 1 i 8. početak imuniteta: 21 dan nakon završetka primarne sheme cijepljenja. trajanje imuniteta: 12 mjeseci.